Cite
HARVARD Citation
Tabernero, J. et al. (n.d.). 505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine. European journal of cancer. pp. S104-S105. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tabernero, J. et al. (n.d.). 505 Clinical evidence of intra-tumoral immune activation and tumor targeting with RG, a CEA-targeted engineered IL-2 immunocytokine. European journal of cancer. pp. S104-S105. [Online].